Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 21, 2005; 11(11): 1629-1633
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1629

Table 3 Adverse events in the three treatment groups (n, %).

¹See Table 1 for the definition of each group. Patients received the medications for 7 d in each group.

Citation: Isomoto H, Furusu H, Ohnita K, Wen CY, Inoue K, Kohno S. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. World J Gastroenterol 2005; 11(11): 1629-1633
URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1629.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i11.1629

Isomoto H, Furusu H, Ohnita K, Wen CY, Inoue K, Kohno S. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. World J Gastroenterol 2005; 11(11): 1629-1633 [PMID: 15786539 DOI: 10.3748/wjg.v11.i11.1629]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.